Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson's disease-Reference-Cited by-同舟云学术

Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson's disease

Published:2019-08 Issue: Volume:65 Page:224-229
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Hong Chien-Tai^ORCID,Chan Lung^ORCID,Wu Dean,Chen Wan-Ting,Chien Li-Nien

Funder

Health and Clinical Data Research Center

College of Public Health

Taipei Medical University, Taipei, Taiwan

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference25 articles.

1. Parkinson disease;Poewe;Nat. Rev. Dis. Prim.,2017

2. Anticholinergic drugs used in Parkinson's disease: an overlooked class of drugs from a pharmacokinetic perspective;Brocks;J. Pharm. Pharm. Sci.,1999

3. The history of Parkinson's disease: early clinical descriptions and neurological therapies;Goetz;Cold Spring Harb. Perspect. Med.,2011

4. Management of Parkinson׳s disease: current and future pharmacotherapy;Kakkar;Eur. J. Pharmacol.,2015

5. The problems of anticholinergic adverse effects in older patients;Feinberg;Drugs Aging,1993

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attitudes and beliefs towards medication burden and deprescribing in Parkinson disease;BMC Neurology;2024-09-06

2. Leveraging the regulatory framework to facilitate drug development in Parkinson's disease;Handbook of Clinical Neurology;2023

3. Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study;Parkinsonism & Related Disorders;2022-12

4. Motor Symptoms in Dementia With Lewy Bodies: Literature Review and Evidence-Based Management;Psychiatric Annals;2022-10

5. The Role of Plant-based Products in the Prevention of Neurological Complications;Drug Metabolism and Bioanalysis Letters;2022-07